Amino acids

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Homology Medicines, Inc. (FIXX) on Behalf of Investors

Retrieved on: 
Tuesday, October 13, 2020
Legal, Professional services, Amino acids, RTT, Phenylalanine, Phenylketonuria, Homology

Law Offices of Howard G. Smith announces an investigation on behalf of Homology Medicines, Inc. (Homology or the Company) (NASDAQ: FIXX ) investors concerning the Companys possible violations of federal securities laws.

Key Points: 
  • Law Offices of Howard G. Smith announces an investigation on behalf of Homology Medicines, Inc. (Homology or the Company) (NASDAQ: FIXX ) investors concerning the Companys possible violations of federal securities laws.
  • In June 2019, the Company launched a dose-escalation Phase 1/2 clinical trial for HMI-102, its lead product candidate for the treatment of phenylketonuria.
  • Homology "reported encouraging safety and efficacy data from the dose-escalation portion of the trial" and claimed that the data showed HMI-102 "produced a sustained reduction in phenylalanine (Phe)."
  • Moreover, citing internal emails and analyst reports, Mariner Research claimed Homology had selectively discussed the patient's Facebook posts with sell side analysts covering Homology and major investors.

China Pregabalin Market Investigation Report, 2015-2020 & 2020-2024 - ResearchAndMarkets.com

Retrieved on: 
Monday, October 12, 2020
Pharmaceutical, Health, Other Health, Health, Amino acids, Analgesics, Calcium channel blockers, RTT, Anxiolytics, Pregabalin, Pfizer, Pharmaceutical industry, Chongqing

The "Investigation Report on the Chinese Pregabalin Market, 2020-2024 " report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Investigation Report on the Chinese Pregabalin Market, 2020-2024 " report has been added to ResearchAndMarkets.com's offering.
  • For example, the number of epileptics in China has exceeded 10 million and increases by 500 thousand every year.
  • Chongqing Succeway Pharmaceutical Co., Ltd.'s Pregabalin (trade name: Lairuike) was put in the market after obtaining the production license in 2013 and is gradually taking market share from Pfizer.
  • 2 Market Overview of Pregabalin in China, 2013-2018
    2.3 Investigation on Market Size of Pregabalin by Dosage Form in China, 2013-2018
    3 Investigation on Market Share of Major Pregabalin Manufacturers in China, 2013-2018
    3.3 Chongqing Succeway Pharmaceutical Co., Ltd.
    4 Sales Price of Pregabalin in China Market, 2019
    4.2.2 Chongqing Succeway Pharmaceutical Co., Ltd. (Lairuike)
    5 Prospects of Pregabalin Market, 2020-2024
    5.3 Forecast on Market Size of Pregabalin in China, 2020-2024
    View source version on businesswire.com: https://www.businesswire.com/news/home/20201012005627/en/

Pulse Protein Market Is Estimated To Rise At A Steady CAGR Of Over 5% During The 2020-2030

Retrieved on: 
Monday, October 5, 2020
Nutrition, Nitrogen cycle, Articles, Branches of biology, Amino acids, Health, Essential amino acid, Proteins

Pulse protein also has essential amino acids, as compared to animal protein.

Key Points: 
  • Pulse protein also has essential amino acids, as compared to animal protein.
  • The market is estimated to rise at a steady CAGR of over 5% during the forecast period.
  • Owing to the higher utilization rate of pulse protein in bakery & confectionery, snacks, & cereals, and others, food & beverage application is witnessing the highest market value share in the global pulse protein market.
  • Furthermore, pulse protein finds numerous application in the food & beverage industry, which is another beneficial factor for the market.

Pulse Protein Market Is Estimated To Rise At A Steady CAGR Of Over 5% During The 2020-2030

Retrieved on: 
Monday, October 5, 2020
Nutrition, Nitrogen cycle, Articles, Branches of biology, Amino acids, Health, Essential amino acid, Proteins

Pulse protein also has essential amino acids, as compared to animal protein.

Key Points: 
  • Pulse protein also has essential amino acids, as compared to animal protein.
  • The market is estimated to rise at a steady CAGR of over 5% during the forecast period.
  • Owing to the higher utilization rate of pulse protein in bakery & confectionery, snacks, & cereals, and others, food & beverage application is witnessing the highest market value share in the global pulse protein market.
  • Furthermore, pulse protein finds numerous application in the food & beverage industry, which is another beneficial factor for the market.

Neurocrine Biosciences Presents New Data Analyses Demonstrating Efficacy of FDA-Approved Once-Daily ONGENTYS® (opicapone) in Patients with Parkinson's Disease at the MDS Virtual Congress 2020

Retrieved on: 
Friday, September 11, 2020
Drugs, Health, Catecholamines, RTT, Combination drugs, Amino acids, Carbidopa, Hydrazines, Parkinson's disease, L-DOPA, Carbidopa/levodopa/entacapone, Management of Parkinson's disease

These data are among several studies and analyses of ONGENTYS being presented in collaboration with BIAL at the MDS Virtual Congress 2020 on September 1216 ( www.mdscongress.org/Congress/Registration.htm ).

Key Points: 
  • These data are among several studies and analyses of ONGENTYS being presented in collaboration with BIAL at the MDS Virtual Congress 2020 on September 1216 ( www.mdscongress.org/Congress/Registration.htm ).
  • "The Phase III post-hoc data analyses demonstrated the benefit of adding once-daily ONGENTYS to levodopa/carbidopa in patients with Parkinson's disease who have motor fluctuations.
  • "These data analyses demonstrated the benefit of adding once-daily ONGENTYS to levodopa/carbidopa earlier in the treatment regimen of patients with Parkinson's disease.
  • Similarly, hospitalizations were significantly more frequent in patients with a longer history of motor fluctuations (15% [n=18] vs 6% [n=12], P

AgilVax Progress Triggers $1.2 Million SBIR Fast-Track Grant to Advance Antibody-Based Therapy

Retrieved on: 
Tuesday, August 18, 2020
Research, Public relations, Investor relations, Genetics, Communications, Clinical trials, Biotechnology, Health, Pharmaceutical, Science, Amino acids, Organic compounds, Solute carrier family, Cystine/glutamate transporter, Biotechnology, Thiols, Cystine, Cysteine, Antibody-drug conjugate, Glutamate, Reactive oxygen species, Glutamate receptor

AgilVax successfully achieved its goals from the earlier phases allowing the final portion of the grant to be awarded.

Key Points: 
  • AgilVax successfully achieved its goals from the earlier phases allowing the final portion of the grant to be awarded.
  • AgilVax has three development programs targeting xCT, a cystine-glutamate antiporter: (1) an antibody-drug conjugate (xCT-mAb-ADC), (2), a conjugated radiopharmaceutical and (3) AX09.
  • xCT expression is low in normal cells but elevated in numerous cancer types corresponding to increases in intracellular reactive oxygen species (ROS).
  • AgilVax discovers and develops antibody-based therapeutics for the treatment of various cancers targeting xCT (SLC7A11), a cystine-glutamate antiporter.

Global Amino Acids Market (2020 to 2027) - Size, Share & Trends Analysis Report - ResearchAndMarkets.com

Retrieved on: 
Monday, August 17, 2020
Professional services, Consulting, Amino acids, Proteinogenic amino acids, Zwitterions, Essential amino acids, Ketogenic amino acids, Nitrogen cycle, Lysine, Dietary supplement, Tryptophan

The "Amino Acids Market Size, Share & Trends Analysis Report By Source (Plant Based, Animal Based), By Product (L-glutamate, Lysine, Tryptophan), By Application, By Livestock, By Region, And Segment Forecasts, 2020 - 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Amino Acids Market Size, Share & Trends Analysis Report By Source (Plant Based, Animal Based), By Product (L-glutamate, Lysine, Tryptophan), By Application, By Livestock, By Region, And Segment Forecasts, 2020 - 2027" report has been added to ResearchAndMarkets.com's offering.
  • The global amino acids market size is projected to reach USD 40.3 billion by 2027., expanding at a CAGR of 7.8% from 2020 to 2027.
  • Research and development activities related to improving the yield and quality of extracted amino acids are being carried out across the globe.
  • The food and dietary supplements application segment dominated the market for amino acids in 2019.

Cambrooke Introduces Advanced New Hypoallergenic Amino Acid-based Formulas: EquaCare Jr.™ and Essential Care Jr.™

Retrieved on: 
Wednesday, July 8, 2020
Baby, Maternity, Practice Management, Managed care, Health, General Health, Food, Beverage, Retail, Family, Hospitals, Fitness & Nutrition, Consumer, Articles, Branches of biology, Nitrogen cycle, Amino acids, Amino acid-based formula, Infant feeding, Ajinomoto, Essential amino acid, Leucine, Nutrition, Nutrient, Animal nutrition

Ajinomoto Cambrooke, Inc., a U.S.-based therapeutic nutrition company and global provider of medical nutrition products, today introduced two essentially better hypoallergenic amino acid-based formulas for children: EquaCare Jr. and Essential Care Jr .

Key Points: 
  • Ajinomoto Cambrooke, Inc., a U.S.-based therapeutic nutrition company and global provider of medical nutrition products, today introduced two essentially better hypoallergenic amino acid-based formulas for children: EquaCare Jr. and Essential Care Jr .
  • EquaCare Jr. helps alleviate this burden, providing the essential nutrients a growing child needs, but at dramatic cost savings over similar amino acid-based formulas, said Howard Lossing, CEO of Ajinomoto Cambrooke.
  • Essential Care Jr. contains natural ingredients and is unique among leading amino acid-based formulas in being the only one with absolutely no corn syrup solids.
  • Essential Care Jr. uses Ajipure pharmaceutical-grade vegan amino acids and a proprietary blend of essential amino acids with increased leucine that may help build muscle.

GOLIKE Shake & Drink Makes the Intake of the Amino Acid Mix as Easy as Drinking a Glass of Water

Retrieved on: 
Sunday, June 28, 2020
Amino acids, Newborn screening, Rare diseases, Intellectual disability, Phenylketonuria, RTT, Phenylalanine, Hyperphenylalaninemia

BALERNA, Switzerland, June 28, 2020 /PRNewswire/ -- From now on, people living and dealing with PKU have the possibility to easily sip PKU GOLIKE with GOLIKE Shake & Drink.

Key Points: 
  • BALERNA, Switzerland, June 28, 2020 /PRNewswire/ -- From now on, people living and dealing with PKU have the possibility to easily sip PKU GOLIKE with GOLIKE Shake & Drink.
  • PKU GOLIKE is a phenylalanine-free amino acid mix, which represents an evolution in the dietary management of phenylketonuria.
  • The PKU GOLIKE innovation lies in the special coating of the amino acids that gives rise to a formulation in granules with special characteristics.
  • GOLIKE Shake & Drink thus provides a practical way of drinking the PKU GOLIKE mix in granules.

GOLIKE Shake & Drink Makes the Intake of the Amino Acid Mix as Easy as Drinking a Glass of Water

Retrieved on: 
Sunday, June 28, 2020
Amino acids, Newborn screening, Rare diseases, Intellectual disability, Phenylketonuria, RTT, Phenylalanine, Pku, Hyperphenylalaninemia

APR Applied Pharma Research s.a. ("APR") proposes a new ally for patients with Phenylketonuria ("PKU"): GOLIKE Shake & Drink, a handy bottle of slightly gelled water that makes the PKU GOLIKEamino acid mix quick and easy to drink.

Key Points: 
  • APR Applied Pharma Research s.a. ("APR") proposes a new ally for patients with Phenylketonuria ("PKU"): GOLIKE Shake & Drink, a handy bottle of slightly gelled water that makes the PKU GOLIKEamino acid mix quick and easy to drink.
  • BALERNA, Switzerland, June 28, 2020 /PRNewswire/ -- From now on, people living and dealing with PKU have the possibility to easily sip PKU GOLIKE with GOLIKE Shake & Drink.
  • PKU GOLIKE is a phenylalanine-free amino acid mix, which represents an evolution in the dietary management of phenylketonuria.
  • GOLIKE Shake & Drink thus provides a practical way of drinking the PKU GOLIKE mix in granules.